Manulife (Manufacturers Life Insurance)
IRD

Manulife (Manufacturers Life Insurance)’s Opus Genetics IRD Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-5
Closed -$1 – 3842
2013
Q4 		$1 Hold
5
– – ﹤0.01% 3761
2013
Q3 		$1 Hold
5
– – ﹤0.01% 3617
2013
Q2 		$1K Buy
+5
New +$858 ﹤0.01% 3495

Other funds holding IRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s IRD Position: Q1 2014 in Review

Manulife (Manufacturers Life Insurance) sold out of Opus Genetics (IRD) in Q1 2014, closing a stake of 5 shares — an estimated $1 sold.

Manulife (Manufacturers Life Insurance) first reported a position in IRD in Q2 2013 and held it in 3 quarters. The position peaked at $1K in Q2 2013. 35 funds tracked by Wall St. Rank hold IRD as of Q1 2014.

  • Manulife (Manufacturers Life Insurance) reported no remaining Opus Genetics position as of Q1 2014 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 5 Opus Genetics shares in Q1 2014, an estimated $1.
  • Manulife (Manufacturers Life Insurance) first reported a position in Opus Genetics in Q2 2013 and held it in 3 quarters.
  • Manulife (Manufacturers Life Insurance)'s Opus Genetics position peaked at $1K in Q2 2013.
  • 35 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2014.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2014, filed 13 May 2014.